-
The annual treatment cost of multiple drugs exceeds $1 million!
Time of Update: 2022-10-01
Recently, Bluebird Bio announced that the FDA has accelerated the approval of the company's gene therapy drug Skysona (elivaldogene autotemce, eli-cel), which is used to treat a rare neurological disease cerebral adrenoleukodystrophy (CALD), and is the world's first approved one-time gene therapy for the treatment of early CALD.
-
China will build 120 provincial-level regional medical centers to facilitate the treatment of patients with serious diseases
Time of Update: 2022-10-01
According to the National Health Commission, during the "14th Five-Year Plan" period, the state will support the construction of about 120 provincial-level regional medical centers in various places, promote the extension of high-quality medical resources to the masses, and reduce medical treatment in different places as much as possible.
-
Announcement of the State Food and Drug Administration on the Conversion of Prescription Drugs for Deficiency Deficiency and Thirst-Quenching Agent into Over-the-Counter Drugs (No. 134 [2021])
Time of Update: 2022-10-01
doc According to the "Measures for the Classification and Administration of Prescription Drugs and Non-prescription Drugs (Trial)" (formerly Order No. 10 of the State Drug Administration), after the demonstration and approval organized by the State Drug Administration, the compound was converted from prescription drugs to over-the-counter drugs.
-
China's pharmaceutical machinery enterprises are accelerating their competitiveness through acquisitions and capital increases!
Time of Update: 2022-10-01
In recent years, China's pharmaceutical market has shown a rapid growth trend, the growing market has attracted many competitors, many of which foreign pharmaceutical equipment giants have also increased their sales efforts and investment scale in the Chinese market, and with the advantages of capital, technology, talent, equipment, research and development and other aspects occupy the main market share of domestic high-end pharmaceutical equipment.
-
There are 41 public TCM medical institutions at the second level or above in Beijing
Time of Update: 2022-10-01
He said that in the past ten years, the comprehensive service capacity of traditional Chinese medicine and medical care in Beijing has continued to improve, the social contribution of traditional Chinese medicine has been significantly enhanced, the cultural inheritance has been carried forward and developed, the results of foreign exchanges have been fruitful, and the work of traditional Chinese medicine has achieved leapfrog development.
-
Pharmacies in many places began to sell medicine collection at zero price!
Time of Update: 2022-10-01
Prior to this, the Hebei Medical Insurance Bureau issued the "Notice on Including Eligible Designated Retail Pharmacies in the Scope of Outpatient Protection", which mentioned that outpatient co-ordination pharmacies sell nationally and provincial centrally procured drugs (including original research drugs, reference preparations, and generic drugs that have passed consistency evaluation under the same generic name), and use the selected price as the medical insurance payment standard.
-
Asri Health Lecture Hall: Efficacy Analysis of Pifenidone in Patients with RA-ILD
Time of Update: 2022-10-01
【Research Progress】 According to a study published in The Lancet in September, a randomized, double-blind, placebo-controlled Phase 2 study was presented to validate safety, tolerability, and efficacy in patients with rheumatoid arthritis-associated interstitial lung disease.
-
Financing is active in the pharmaceutical sector, and such companies are gaining favor
Time of Update: 2022-10-01
On September 19, Saipu Bio also announced that the company completed a series B financing of hundreds of millions of yuan.
On September 19, Saipu Bio also announced that the company completed a series B financing of hundreds of millions of yuan.
-
"Planting + processing" Qinghai Dulan red goji berries drive farmers to increase their income and become rich
Time of Update: 2022-10-01
buyers Dulan County is located in the southeast of the Qaidam Basin, with an average altitude of 3100 meters, most of the county is desert Gobi, once a poor county in Qinghai Province.
-
Aiming at this difficult 100 billion market, domestic and foreign pharmaceutical companies are facing difficulties
Time of Update: 2022-10-01
In the face of this difficult but huge space market, including Eli Lilly, Johnson & Johnson, Roche, AbbVie, Merck, as well as a large number of domestic and foreign pharmaceutical companies such as Green Valley Pharmaceutical, Dongguang Pharmaceutical, Haizheng Pharmaceutical, Tonghua Jinma and so on, have risen to the challenge and actively laid out.
-
The domestic innovative drug market has nearly 10x growth space, or it will bring demand expansion to the upstream
Time of Update: 2022-10-01
In the first half of this year, the profit growth rate of the pharmaceutical equipment industry remained at about 10%, of which the industry head represented by Chutian Technology and Dongfulong performed more brightly, and the growth rate of revenue and net profit was higher.
-
49 exclusive proprietary Chinese medicines are on the light! 5 more than 1 billion varieties to participate in the war
Time of Update: 2022-10-01
The 250 billion yuan Chinese patent medicine hospital market is booming again! Recently, the 2022 National Medical Insurance Catalogue was released through the formal review list, and 50 proprietary
-
The collection of proprietary Chinese medicines in 30 provinces will begin to be reported
Time of Update: 2022-10-01
The provincial medical insurance departments in the alliance area organize the review of the historical procurement volume and procurement demand of medical institutions.
The provincial medical insurance departments in the alliance area organize the review of the historical procurement volume and procurement demand of medical institutions.
-
The five major provinces are the first to announce! Over 600 symbols unlock "new usages"
Time of Update: 2022-10-01
Since the official implementation of the new version of the Physicians Law in March this year, Guangdong, Shandong, Liaoning, Jilin and Heilongjiang provinces have successively issued the "2022 editi
-
The demand for core talents in the pharmaceutical industry expanded, and more than 200 senior executives of pharmaceutical companies took up new positions during the year
Time of Update: 2022-10-01
Also in April, Zou Jianjun, who served as the chief medical officer and deputy general manager of Hengrui Pharmaceutical, joined Junshi Bio eight days after leaving his post and served as the company's executive director, deputy general manager and global R&D president, fully responsible for the company's global research and development work.
-
Notice of the State Food and Drug Administration on the Issuance of the "Matters Concerning the Change of Listed Biological Products and the Requirements for Declaration Information" (No. 40 [2021])
Time of Update: 2022-10-01
doc to Notice No. 40 of 2021 of the State Drug Administration In order to cooperate with the implementation of the Measures for the Administration of Drug Registration, the State Drug Administration has organized and formulated the "Requirements for Changes and Declaration Materials of Listed Biological Products", which is hereby issued.
-
Policy increases, the proximity of collection and procurement have forced the transformation and upgrading of Chinese medicine enterprises
Time of Update: 2022-10-01
companies A number of national-level blockbuster policies such as the "14th Five-Year Plan" National Drug Safety and Promotion of High-quality Development, the "14th Five-Year Plan for the Development of Traditional Chinese Medicine" and other national blockbuster policies have been introduced, continuously increasing support for the traditional Chinese medicine industry and encouraging innovation in the traditional Chinese medicine industry; It also puts forward high requirements for the quality of Chinese herbal medicines, quality control of traditional Chinese medicines, and standardized production.
-
The pharmaceutical industry is active in mergers and acquisitions, and at the end of September, another pharmaceutical company announced a restructuring!
Time of Update: 2022-10-01
Since September this year, mergers and acquisitions in the pharmaceutical industry have been active, including Darentang's proposed acquisition of no more than 11. 9686 million shares of Keju Biologic
-
China has further expanded the scope of implementation of the policy of deferring the payment of social security premiums
Time of Update: 2022-10-01
The General Offices of the Ministry of Human Resources and Social Security, the National Development and Reform Commission, the Ministry of Finance, and the State Administration of Taxation recently
-
A large number of prescription drugs have been converted to over-the-counter drugs, mostly proprietary Chinese medicines
Time of Update: 2022-10-01
The industry believes that the pain relief capsules are proprietary Chinese medicines, and the product is not transferable, or it is expected to get more sales growth, and it will also be more convenient for patients to buy the drug in offline pharmacies and online e-commerce platforms.
